Berendes, Sima
Mounier-Jack, Sandra
Ojo-Aromokudu, Oyinkansola
Ivory, Alice
Tucker, Joseph D.
Larson, Heidi J.
Free, Caroline
Article History
Received: 31 March 2023
Accepted: 15 July 2023
First Online: 21 July 2023
Declarations
:
: This study has been approved by the NHS London—South East Research Ethics Committee (ref: 22/LO/0025) and the LSHTM Research Ethics Committee (ref: 27160) and all methods were carried out in accordance with the appropriate guidelines and regulations. Written informed consent was obtained for face-to-face interviews and oral informed consent for the remotely conducted interviews and focus group discussion. Oral consent was audio-recorded, as agreed upon with the Ethics Committees.
: Not applicable (all data anonymized).
: The research group of one of the co-authors, H.J.L., has received grants from the Bill & Melinda Gates Foundation, GSK, Johnson & Johnson, MacArthur Foundation, YouTube, Merck, NIHR and UNICEF. All other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. [SB supported some of the work conducted in H.J.L.’s research group prior to the start of the VIP-IDEAL study.]